Anti-Infective Agents Market is expected to reach US$ 1,64,196.61 Million by 2028

Terahertz Imaging Segment to Dominate Anti-Infective Agents Market in 2022

According to The Insight Partners research study on "Anti-Infective Agents Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Range, Route of Administration, Indication, and Distribution Channel," the market is expected to grow from US$ 1,35,961.03 million in 2022 to US$ 1,64,196.61 million by 2028; it is estimated to grow at a CAGR of 3.19% from 2022 to 2028. The rising prevalence of targeted diseases and rising government support for research activities and clinical trials are the factors that contribute to the anti-infective agents market growth. However, the emergence of anti-infective drug resistance and its side effects restrict the market growth.

Many well-known firms have medicines that include anti-fungal, antibiotics, bacteria, protozoans, and anti-virals that target cytochrome, interleukin, and interferons, and othermulti-drug resistant. The primary factor fueling the anti-infective agents market growth is the rising prevalence of several infectious diseases in developed and developing economies, including various strains of influenza, diarrhea, hepatitis, and urinary tract infections, which call for increased attention from the pharmaceutical & biotechnology industries. Additionally, there has been a large increase in the number of multidrug-resistant organisms in various regions, which emphasizes the significance of anti-infective agent innovation even more.

Based on range, the anti-infective agents market is bifurcated into narrow spectrum and broad spectrum. The narrow spectrum segment is expected to hold a larger market share in 2022. However, the broad spectrum segment is anticipated to register a higher CAGR during the forecast period. Narrow spectrum antibiotics are effective against only a limited range of organisms. Furthermore, the advancements in the treatment are likely to develop more advanced drugs in the coming years. When the causative agent is recognized, narrow spectrum antibiotics are utilized to treat the specific infection since they do not destroy as many normal microorganisms as broad-spectrum antibiotics. Therefore, it is less likely to result in superinfection. This reduces bacterial resistance since they exclusively affect certain types of bacteria, such as Azithromycin (a macrolide antibiotic belonging to the azalide subclass) and Clarithromycin. Several global players have well-established R&D with an increased focus on the development of narrow spectrum drugs to avoid the occurrence of multidrug-resistant organisms.

Infectious diseases are anticipated to be a major global public health concern. Diseases can develop for numerous reasons, including infections contracted in the community or from hospitals. There are many distinct forms of infections, such as those caused by fungus, bacteria, viruses, and parasites. Therefore, one of the key factors fueling the growth of the global anti-infective agents market is the increased incidence of infectious disorders.

The market for anti-infective agents witnessed increased demand due to changes in demographics. By 2030, the world's population is expected to increase from its current estimated 7.7 billion people to 8.5 billion people. The aging of the population is a global phenomenon, as the proportion of people over 65 is expected to quadruple from 2019 to 2050. Moreover, more people are moving into cities and becoming wealthy, especially in China, where the middle class is growing at the fastest rate ever recorded and where, by 2027, 1.2 billion people—or one-fourth of the world's population—is expected to be middle class. Therefore, the growing elderly population globally supports the expansion of the anti-infective agent market.

Abbott; Allergan Plc.; Astellas Pharma Inc.; Merck & Co., Inc.; Bayer AG; Bristol-Myers Squibb Company; Boehringer Ingelheim International GmbH; F. HOFFMANN-LA ROCHE Ltd.; Gilead Sciences, Inc.; GlaxoSmithKline plc.; and Novartis AG are the key companies operating in the anti-infective agents market.

Anti-Infective Agents Market, by Region, 2022 (%)

---

Anti-Infective Agents Market Size, Share and Growth Analysis

Download Free Sample

---

Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum),  Route of Administration (IV, Oral, Topical, and Others) Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)

The report segments the anti-infective agents market as follows:

The anti-infective agents market is segmented into type, range, route of administration, indication, distribution channel, and geography. Based on type, the market is segmented into anti-viral, anti-bacterial, anti-fungal, and others. Based on range, the anti-infective agents market is bifurcated into narrow spectrum and broad spectrum. Based on route of administration, the anti-infective agents market is segmented into IV, oral, topical, and others. Based on indication, the anti-infective agents market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. Based on distribution channel, the anti-infective agents market is categorized into hospital pharmacies, retail pharmacies, specialty pharmacies, e-commerce, and others. By geography, the anti-infective agents market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com